The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to tinostamustine, an investigational therapeutic from Purdue Pharma L.P., for the treatment of patients with malignant ...

Purdue Pharma L.P. ("Purdue") today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its pipeline drug tinostamustine for the treatment of ...

A former aide to two New York governors is set to go on trial Wednesday on charges she sold her influence to the Chinese ...

The investigational, potentially first-in-class agent tinostamustine (EDO-S101) has earned FDA orphan drug designation (ODD) ...

Lawyers representing OxyContin maker Purdue Pharma, branches of the Sackler family that own it, cities, states, counties, ...

While AI has accelerated drug discovery, the same technology can address clinical trial bottlenecks that have persisted for ...

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler families, from ...

The Supreme Court wrapped up its arguments for the November sitting yesterday and announced what cases it will hear in January. Mark your calendars accordingly – we certainly have! SCOTUS […] The post ...

(NEW YORK) -- A federal judge in New York decided the wealthy Alexander brothers must face charges they conspired for more than a decade to drug, sexually assault and rape dozens of women, rejecting ...